Regulation, functions and therapeutic strategies of H2AK119ub1.

Biochem Pharmacol

School of Pharmacy and Science, Institute of Clinical Pharmacology, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Anhui Medical University, Hefei 230032, China. Electronic address:

Published: October 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Histone H2A monoubiquitination at lysine 119 (H2AK119ub1) is a central epigenetic regulator that governs transcriptional control, chromatin architecture remodeling, and lineage commitment. The precise homeostatic balance of H2AK119ub1 is maintained through antagonistic coordination between polycomb repressive complex 1 and specialized deubiquitinases, forming a precise equilibrium that is critical for the regulation of gene expression. Dysregulation of H2AK119ub1 has been mechanistically linked to multiple human pathologies, indicating that its regulatory axis is a promising therapeutic target. This review provides a comprehensive analysis of the molecular mechanisms underlying H2AK119ub1 deposition/removal, its causal relationships with disease progression, and current pharmacological strategies targeting this pathway. This study offers novel perspectives on H2AK119ub1-mediated epigenetic regulation and proposes a framework for developing targeted therapeutic interventions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2025.117122DOI Listing

Publication Analysis

Top Keywords

h2ak119ub1
5
regulation functions
4
functions therapeutic
4
therapeutic strategies
4
strategies h2ak119ub1
4
h2ak119ub1 histone
4
histone h2a
4
h2a monoubiquitination
4
monoubiquitination lysine
4
lysine 119
4

Similar Publications

Polycomb Repressive Complex 1 (PRC1) catalyzes H2AK119ub1 to facilitate transcriptional repression during development. dominant missense variants in , the principal E3 ligase of PRC1, are the genetic basis of Luo-Schoch-Yamamoto syndrome. To investigate the developmental impact of catalytically impaired RNF2 alleles, we engineered hESC lines harboring homozygous hypomorphic missense alleles ( ) that stably expresses RNF2 but results in reduced H2AK119ub1.

View Article and Find Full Text PDF

Mouse oocytes exhibit a unique chromatin landscape characterized by broad H3K27ac and H3K27me3 domains, demarcating euchromatin and facultative heterochromatin, respectively. However, the mechanisms underlying this non-canonical landscape remain elusive. Here we report BAP1, a core component of the Polycomb Repressive-Deubiquitinase (PR-DUB) complex, as a key negative regulator of Polycomb activity during oogenesis.

View Article and Find Full Text PDF

In mouse, minor zygotic genome activation (ZGA) precedes and is essential for major ZGA in two-cell (2C) embryos. A subset of ZGA genes (known as "2C" genes) are also activated in a rare population of embryonic stem cells (ESCs) (2C-like cells). However, the functions of the 2C genes are not fully understood.

View Article and Find Full Text PDF

Polycomb repressive complex 1.6 (PRC1.6), one of the PRC1 subtypes, plays crucial roles in preventing the ectopic expression of meiosis-related genes in mouse embryonic stem cells (ESCs).

View Article and Find Full Text PDF

Structural mechanism of H3K27 demethylation and crosstalk with heterochromatin markers.

Mol Cell

August 2025

Center for Integrative Chemical Biology and Drug Discovery, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hi

Article Synopsis
  • H3K27me3 is a repressive histone modification linked to facultative heterochromatin, established by PRC2 and removed by KDM6 family demethylases.
  • Cryo-EM studies reveal how KDM6B interacts with nucleosomal and extranucleosomal DNA to effectively demethylate H3K27, a step essential for reactivating silenced chromatin.
  • Additional findings suggest that linker histones and H2AK119ub1 inhibit KDM6B activity, indicating their removal is necessary for successful H3K27 demethylation and activation of heterochromatin.
View Article and Find Full Text PDF